[O15] COVID-19・その他

[O15-1] Survey of COVID-19-affected neuromuscular disease patients in Japan

^○Takatoshi Sato¹, Keiko Ishigaki¹, Yuki Kihara¹, Kumiko Ishiguro¹, Minobu Shichiji¹, Satoru Nagata¹, Hajime Arahata², Ruriko Kitao³, Akiko Wakisaka⁴, Michinori Funato⁵, Katshuhisa Ogata⁶, Hirofumi Komaki⁷, Masanori P. Takahashi⁸, Yasuhiro Takeshima⁹, Tsuyoshi Matshumura¹⁰ (1.Department of Pediatrics, Tokyo Women's Medical University, Tokyo, JAPAN, 2.Department of Neurology, National Hospital Organization Omuta Hospital, Omuta, Japan, 3.Department of Neurology, National Hospital Organization Hakone Hospital, Kanagawa, Japan, 4.Department of Pediatrics, National Hospital Organization Iou Hospital, Ishikawa, Japan, 5.Department of Neurology, National Hospital Organization Nagara Medical Center, Nagara, Japan, 6.Department of Neurology, National Hospital Organization Higashisaitama Hospital, Hasuda, Japan, 7.Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan, 8.Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan, 9.Department of Pediatrics, Hyogo Medical University School of Medicine, Nishinomiya, Japan, 10.Department of Neurology, National Hospital Organization Osaka Toneyama Medical Center)